NCT02283112 Validation of Drug Assays in Various Biological Matrices
| NCT ID | NCT02283112 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Liverpool |
| Condition | Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2014-10 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2014-10 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to ensure that assays that measure drug concentrations are accurate and precise in different matrices when quantified using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS). The study involves collecting samples of various bodily fluids to quantify antimicrobials, antivirals, oral contraceptives and erectile dysfunction agents. Samples will also be obtained from individuals not receiving these medications for quality control purposes.
Eligibility Criteria
Inclusion Criteria: * \> 18 years of age Exclusion Criteria: * Unable to give informed consent
Contact & Investigator
Helen Reynolds
✉ TherEx-trials@liverpool.ac.ukSaye Khoo
PRINCIPAL INVESTIGATOR
University of Liverpool
Frequently Asked Questions
Who can join the NCT02283112 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02283112 currently recruiting?
Yes, NCT02283112 is actively recruiting participants. Contact the research team at TherEx-trials@liverpool.ac.uk for enrollment information.
Where is the NCT02283112 trial being conducted?
This trial is being conducted at Liverpool, United Kingdom.
Who is sponsoring the NCT02283112 clinical trial?
NCT02283112 is sponsored by University of Liverpool. The principal investigator is Saye Khoo at University of Liverpool. The trial plans to enroll 100 participants.